A G Schenk, G A Peyman. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Abscess/etiologyAbscess/pathologyAnimalsDisease Models, AnimalEye/pathologyEye Diseases/drug therapyEye Diseases/etiologyEye Diseases/pathologyInjections/methodsLincomycin/administration & dosageLincomycin/metabolismLincomycin/therapeutic useLincomycin/toxicityMetabolic Clearance RatePanophthalmitis/etiologyPanophthalmitis/pathologyRabbitsRetina/pathologyRetinal Diseases/chemically inducedRetinal Diseases/pathologyStaphylococcal Infections/drug therapyStaphylococcal Infections/etiologyStaphylococcal Infections/pathologyTime FactorsVitreous Body/metabolism
Substances: See more » Lincomycin
Year: 1974 PMID: 4547926 DOI: 10.1007/bf00407889
Source DB: PubMed Journal: Albrecht Von Graefes Arch Klin Exp Ophthalmol ISSN: 0065-6100